Mallinckrodt plc
Drug Manufacturers-Specialty & Generic
Healthcare
MNK
13.20 M shares
NYSE US
traded
08 Aug 2023
listed
no
open
1.69
52 week high
26.75
high
2.04
52 week low
1.34
low
1.35
growth
-87.22 %
previous Close
1.81
P/E ratio
-0
market cap
11.46 M
div yield
0
usd
Mar 2023
qoq
revenue
425 M
-26.07 %
net incoming
-249.30 M
20.40 %
eps
-18.89 %
0.08 %
eps surprise
0.00 %
net profit margin
-58.71 %
-4.00 %
operating incoming
-111.30 M
31.97 %
net change in cash
70.20 M
290.76 %
cash on hand
480 M
17.22 %
cost of revenue
375 M
-30.73 %
top top